https://www.selleckchem.com/
Patient survival at 1 and 3 years was similar among younger age groups, whereas patient survival was significantly lower in elderly recipients at 1 (60%) and 3 years (40%) ( = 0.0077). Control analyses (replicating Scientific Registry of Transplant Recipient's survival stratification 18-45, 46-64, ≥65 y) showed similar patient survival in all age groups. Although LT can be safely performed in elderly recipients, extreme caution is needed in CLKT due to the magnitude of operation. Although LT can be safely performed in elderly recipients, extreme caution is